Hack JB, Watkins JC, Schreiber JM, Hammer MF, et al. Patients carrying pathogenic SCN8A variants with loss- and gain-of-function effects can be classified into five subgroups exhibiting varying developmental and epileptic components of encephalopathy. Epilepsia 2024;65:3324-3334.
PMID: 39556335